Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Leslie Cho MD, FACC, FSCAI, FESC

Leslie Cho MD, FACC, FSCAI, FESC

Professor of Medicine, Cleveland Clinic Lerner School of Medicine Case Western Reserve Medical School; Section Head, Preventive Cardiology and Cardiac Rehabilitation; Director of Women's Cardiovascular Center, Cleveland Clinic,

Leslie Cho, MD, is Director of the Cleveland Clinic's Women's Cardiovascular Center. She is also Section Head, Preventive Cardiology and Rehabilitation and Vice Chair of Heart Vascular Thoracic Institute at Cleveland Clinic. She is a professor of Medicine at Cleveland Clinic Lerner School of Medicine Case Western Reserve Medical School. Dr. Cho is ACC CVD in Women Committee chair.

Disclosures

Dr. Cho reports the following:

Research - Esperion, AstraZeneca, Novartis

Consulting - Merck, Esperion

Recent Contributions to PracticeUpdate:

  1. Effect of Bempedoic Acid on Cardiovascular Outcomes by Sex